share_log

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update

SEC ·  May 15, 2023 19:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more